Gallen consensus meeting recommended that hormone receptor-positive/HER2-negative breast cancer should be divided into the luminal A-like type (high ER/PgR and clearly low Ki67) and the luminal B-like type (low ER/PgR and clearly high Ki67)32. This evidence concerns the gene MKI67 and breast carcinoma.